CY2282B1 - Diphenyl alkyl-tetrahydropyridines process for their preparation and pharmaceutical compositions containing them - Google Patents

Diphenyl alkyl-tetrahydropyridines process for their preparation and pharmaceutical compositions containing them

Info

Publication number
CY2282B1
CY2282B1 CY0200036A CY0200036A CY2282B1 CY 2282 B1 CY2282 B1 CY 2282B1 CY 0200036 A CY0200036 A CY 0200036A CY 0200036 A CY0200036 A CY 0200036A CY 2282 B1 CY2282 B1 CY 2282B1
Authority
CY
Cyprus
Prior art keywords
pct
preparation
pharmaceutical compositions
compositions containing
tetrahydropyridines
Prior art date
Application number
CY0200036A
Other languages
English (en)
Inventor
Marco Baroni
Rosanna Cardamone
Jacqueline Fournier
Umberto Guzzi
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of CY2282B1 publication Critical patent/CY2282B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CY0200036A 1996-12-13 2002-05-15 Diphenyl alkyl-tetrahydropyridines process for their preparation and pharmaceutical compositions containing them CY2282B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615336A FR2757161B1 (fr) 1996-12-13 1996-12-13 Diphenylalkyl-tetrahydropyridines

Publications (1)

Publication Number Publication Date
CY2282B1 true CY2282B1 (en) 2003-07-04

Family

ID=9498642

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0200036A CY2282B1 (en) 1996-12-13 2002-05-15 Diphenyl alkyl-tetrahydropyridines process for their preparation and pharmaceutical compositions containing them

Country Status (31)

Country Link
US (1) US6124318A (no)
EP (1) EP0950049B1 (no)
JP (1) JP2001505903A (no)
KR (1) KR100549656B1 (no)
CN (1) CN1144784C (no)
AT (1) ATE207056T1 (no)
AU (1) AU730142B2 (no)
BR (1) BR9713926A (no)
CA (1) CA2274946C (no)
CY (1) CY2282B1 (no)
CZ (1) CZ290242B6 (no)
DE (1) DE69707504T2 (no)
DK (1) DK0950049T3 (no)
EE (1) EE03764B1 (no)
ES (1) ES2167805T3 (no)
FR (1) FR2757161B1 (no)
HK (1) HK1024001A1 (no)
HU (1) HUP0001437A3 (no)
IL (2) IL130001A0 (no)
IS (1) IS2001B (no)
NO (1) NO313282B1 (no)
NZ (1) NZ336032A (no)
PL (1) PL192926B1 (no)
PT (1) PT950049E (no)
RS (1) RS49672B (no)
RU (1) RU2198874C2 (no)
SI (1) SI0950049T1 (no)
SK (1) SK283332B6 (no)
TR (1) TR199901290T2 (no)
UA (1) UA52708C2 (no)
WO (1) WO1998025904A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
US20030060487A1 (en) * 2000-04-12 2003-03-27 Bamdad R. Shoshana Treatment of neurodegenerative disease
WO2002083863A2 (en) 2001-04-17 2002-10-24 Sepracor, Inc. Thiazole and other heterocyclic ligands and use thereof
US20050191349A1 (en) * 2003-12-31 2005-09-01 Garth Boehm Galantamine formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1321701A (en) * 1969-10-01 1973-06-27 Continental Pharma Amino-alcohols their salts and process for prepairing the same
BE775611A (fr) * 1970-11-24 1972-03-16 Synthelabo Derives de la (diphenyl-3,3 propyl-1)-1 piperidine, leur preparation etles medicaments qui en contiennent
FR2650505B1 (fr) * 1989-08-07 1994-06-03 Midy Spa Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale
US5266573A (en) * 1989-08-07 1993-11-30 Elf Sanofi Trifluoromethylphenyltetrahydropyridines for the treatment and/or prophylaxis of intestinal motility disorders
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5512584A (en) * 1991-04-16 1996-04-30 Basf Aktiengesellschaft 1,3,4-trisubstituted piperidine derivatives, the preparation and use thereof
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds
DK148392D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocykliske forbindelser

Also Published As

Publication number Publication date
PL192926B1 (pl) 2006-12-29
CN1144784C (zh) 2004-04-07
IS5074A (is) 1999-06-10
HK1024001A1 (en) 2000-09-29
FR2757161B1 (fr) 1999-03-12
BR9713926A (pt) 2000-03-21
EP0950049A1 (fr) 1999-10-20
RS49672B (sr) 2007-11-15
KR100549656B1 (ko) 2006-02-08
JP2001505903A (ja) 2001-05-08
WO1998025904A1 (fr) 1998-06-18
PT950049E (pt) 2002-03-28
DE69707504D1 (de) 2001-11-22
CA2274946A1 (en) 1998-06-18
NO313282B1 (no) 2002-09-09
NZ336032A (en) 2000-12-22
IS2001B (is) 2005-04-15
EP0950049B1 (fr) 2001-10-17
TR199901290T2 (xx) 1999-08-23
EE9900238A (et) 1999-12-15
CZ211099A3 (cs) 1999-09-15
HUP0001437A2 (hu) 2000-09-28
DE69707504T2 (de) 2002-06-27
AU730142B2 (en) 2001-03-01
YU26399A (sh) 2000-03-21
US6124318A (en) 2000-09-26
CN1240428A (zh) 2000-01-05
ES2167805T3 (es) 2002-05-16
PL334073A1 (en) 2000-01-31
DK0950049T3 (da) 2002-01-28
KR20000069421A (ko) 2000-11-25
FR2757161A1 (fr) 1998-06-19
SK283332B6 (sk) 2003-06-03
EE03764B1 (et) 2002-06-17
IL130001A0 (en) 2000-02-29
SK78799A3 (en) 1999-12-10
AU5489598A (en) 1998-07-03
IL130001A (en) 2006-04-10
NO992870D0 (no) 1999-06-11
CZ290242B6 (cs) 2002-06-12
CA2274946C (en) 2005-09-20
HUP0001437A3 (en) 2001-12-28
UA52708C2 (uk) 2003-01-15
SI0950049T1 (en) 2002-10-31
NO992870L (no) 1999-08-11
ATE207056T1 (de) 2001-11-15
RU2198874C2 (ru) 2003-02-20

Similar Documents

Publication Publication Date Title
FR2727682B1 (no)
ES2141688A1 (es) Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
BR9611618A (pt) Composto processo para sua preparação composição farmacêutica e utilização de um compostos
CY2282B1 (en) Diphenyl alkyl-tetrahydropyridines process for their preparation and pharmaceutical compositions containing them
IL110040A (en) Pyridazinone derivatives their preparation and pharmaceutical compositions comprising them
DE59604901D1 (de) Carbamoylcarbonsäureamide
IL106469A (en) Pyridyl- and pyrimidylpiperazine compounds methods for the manufacture of said compounds and pharmaceutical compositions comprising said compounds
IL109398A0 (en) Benzo (F) quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same